Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 56.61
-2.51 (-4.25%)
Oct 22, 2026, 4:00 PM EDT
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 8.05 billion as of October 22, 2026. It is the 9,012th most valuable company in the world and the 1,873rd biggest in China. Its market cap has increased by 22.80% in one year.
Market Cap
8.05B
Enterprise Value
7.09B
Revenue
630.86M
Global Rank
Country Rank
#1,873 China
PE Ratio
85.51
ChartMarket Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 8.05B, a decrease of -22.83%. That is a compound annual growth rate of -6.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 8.05B | 44.33% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chengzhi | 9.87B |
| Mabwell (Shanghai) Bioscience | 9.85B |
| Staidson (Beijing) BioPharmaceuticals | 9.84B |
| Pacific Shuanglin Bio-pharmacy | 9.12B |
| Novoprotein Scientific | 9.06B |
| InventisBio | 8.90B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.87B |
| Chongqing Genrix Biopharmaceutical | 8.62B |